Open AccessInformation and legal background for remote outpatient care for patients with diabetes mellitus during COVID-19 pandemic
Author(s) -
N. A. Pervyshin,
И В Лебедева,
Elena A. Lebedeva,
С А Суслин
Publication year - 2020
Publication title -
nauka i innovacii v medicine
Language(s) - English
Resource type - Journals
eISSN - 2618-754X
pISSN - 2500-1388
DOI - 10.35693/2500-1388-2020-5-4-251-257
Subject(s) - telemedicine , context (archaeology) , pandemic , medicine , government (linguistics) , isolation (microbiology) , family medicine , medical emergency , health care , covid-19 , disease , pathology , political science , bioinformatics , geography , linguistics , philosophy , biology , archaeology , infectious disease (medical specialty) , law
Objectives the in-depth analysis of the informational and legal base for organisation of remote medical care for patients with diabetes mellitus in the context of the COVID-19 pandemic.
Material and methods. Official memoranda of the WHO and the International Labour Organization (ILO), decisions of the Government of the Russian Federation and foreign countries on the use of remote telemedicine counseling in the context of the COVID-19 pandemic were reviewed and analysed.
Results.After reviewing the results of remote telemedicine counseling to provide specialized medical care to patients with diabetes during COVID-19 pandemic on various virtual platforms, we defined the factors limiting the widespread use of this technology. We collected metadata of the results of the original experience of remote consultation of patients with endocrine pathology using the automated workplace of an endocrinologist (AWPE).
Conclusion.In the context of the COVID-19 pandemic, the development and implementation of new promising forms of outpatient work using digital telecommunication technologies is particularly relevant. The use of remote access telemedicine consulting techniques via Automated endocrinologist's workplace for patients with endocrine pathology during the period of self-isolation showed its effectiveness in a pilot study. Its widespread introduction into outpatient practice will not only significantly increase the availability of medical care for patients with diabetes, but also minimize the risk of infection with a new coronavirus for doctors.